Related Experiment Video
Updated: Dec 31, 2025
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
Published on: June 6, 2025
A novel logical model of COVID-19 intracellular infection to support therapies development
Elena Piretto1, Gianluca Selvaggio2, Damiano Bragantini3
1European Institute of Oncology IRCCS, Milan, Italy.
Abstract:
In this paper, a logical-based mathematical model of the cellular pathways involved in the COVID-19 infection has been developed to study various drug treatments (single or in combination), in different illness scenarios, providing insights into their mechanisms of action. Drug simulations suggest that the effects of single drugs are limited, or depending on the scenario counterproductive, whereas better results appear combining different treatments. Specifically, the combination of the anti-inflammatory Baricitinib and the anti-viral Remdesivir showed significant benefits while a stronger efficacy emerged from the triple combination of Baricitinib, Remdesivir, and the corticosteroid Dexamethasone. Together with a sensitivity analysis, we performed an analysis of the mechanisms of the drugs to reveal their impact on molecular pathways.
Insights
This study models COVID-19 cellular pathways to test drug treatments. Combining Baricitinib, Remdesivir, and Dexamethasone shows the most promising results for effective COVID-19 treatment strategies.
Area of Science:
- Computational biology
- Infectious disease modeling
- Pharmacology
Background:
- COVID-19 infection involves complex cellular pathways.
- Understanding drug mechanisms is crucial for effective treatment.
- Mathematical modeling offers a platform to study these interactions.
Purpose of the Study:
- To develop a logical-based mathematical model of COVID-19 cellular pathways.
- To simulate and evaluate various drug treatments (single and combination).
- To analyze drug mechanisms and their impact on molecular pathways.
Main Methods:
- Development of a logical-based mathematical model.
- In silico simulation of drug treatments.
- Sensitivity analysis of model parameters.
- Analysis of drug mechanisms on molecular pathways.
Main Results:
- Single drug treatments showed limited or scenario-dependent effects.
- Combination therapies yielded better outcomes than monotherapies.
- A triple combination of Baricitinib, Remdesivir, and Dexamethasone demonstrated significant efficacy.
- The study identified specific molecular pathway impacts for each drug.
Conclusions:
- Mathematical modeling is valuable for predicting COVID-19 treatment efficacy.
- Combination drug therapy, particularly Baricitinib, Remdesivir, and Dexamethasone, is a promising strategy.
- Understanding drug-specific mechanisms enhances therapeutic development for COVID-19.
More Related Videos
07:36Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection
Published on: February 28, 2021
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
